Brief: Cara Therapeutics posts Q1 revenue USD 6.2 million
15/05/2023 21:02
May 15 (Reuters) - Cara Therapeutics Q1 net income USD -26.7 million. * Q1 revenue USD 6.2 million
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM